Product Information
METOCLOPRAMIDE 5 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.0371 per EA under NDC 50228023201. Its NADAC has been published 42 times since Sep 10, 2025.
Strength
5 mg/1
Manufacturer
ScieGen Pharmaceuticals, Inc.NDC
50228023201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METOCLOPRAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA072215On Market Since
2/12/2025
Pharmacological Classes
Price Statistics
The NADAC for METOCLOPRAMIDE 5 MG TABLET has been published 42 times since Sep 10, 2025, and over the history we have for it it has declined 13.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0371 per EA |
|---|---|
| All-time high | $0.0433 (Jan 14, 2026) |
| All-time low | $0.0371 (Apr 22, 2026) |
| 52-week high | $0.0433 |
| 52-week low | $0.0371 |
| Median price | $0.0426 |
| Average price | $0.0409 |
| Largest weekly change | -6.0% (Feb 18, 2026) |
| Weeks tracked | 42 |
| Tracking since | Sep 10, 2025 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METOCLOPRAMIDE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METOCLOPRAMIDE 5 MG TABLET, manufactured by ScieGen Pharmaceuticals, Inc., is $0.0371 per EA (NDC 50228023201), effective Jun 24, 2026.
How has the price of METOCLOPRAMIDE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METOCLOPRAMIDE 5 MG TABLET has declined 13.4%. It has been tracked across 42 weekly CMS publications since Sep 10, 2025.
What are the highest and lowest recorded NADAC prices for METOCLOPRAMIDE 5 MG TABLET?
Since Sep 10, 2025, the NADAC for METOCLOPRAMIDE 5 MG TABLET has ranged from a low of $0.0371 (Apr 22, 2026) to a high of $0.0433 (Jan 14, 2026), with a median of $0.0426 per EA.
Are there cheaper alternatives to METOCLOPRAMIDE 5 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as METOCLOPRAMIDE 5 MG TABLET, but none are currently priced below it.
Who manufactures METOCLOPRAMIDE 5 MG TABLET?
METOCLOPRAMIDE 5 MG TABLET (NDC 50228023201) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification